[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 184.73.72.65. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1970

Mesenteric Blood Flow Response to Glucagon AdministrationDuring Temporary Exclusion of the Liver

Author Affiliations

Buffalo
From the Department of Surgery, State University of New York, and the Surgical Research Laboratory, E. J. Meyer Memorial Hospital, Buffalo.

Arch Surg. 1970;100(3):280-283. doi:10.1001/archsurg.1970.01340210056014
Abstract

In recent years cardiovascular effects of glucagon have been demonstrated both in animals and man. Following a single injection of glucagon the hepatic blood flow increased approximately 100%.1,2 This increase in hepatic blood flow is mainly due to a vasodilatory action of glucagon on the splanchnic vascular bed.3 Glucagon exerts positive inotropic and chronotropic effects on the heart.4,5 In dogs, a single injection of glucagon increased the cardiac output 36% and the coronary artery flow 54%.6 The greatest flow increase produced by glucagon (190%) was recorded in the superior mesenteric artery.7

The mechanism by which glucagon exerts its cardiovascular effects is not known. Originally, Shoemaker et al1 suggested that the increase in hepatic blood flow could be a consequence of increased metabolic activity of the liver incident to rapid glycogenolysis. However, the action of glucagon on cardiac performance was as effective on the isolated

First Page Preview View Large
First page PDF preview
First page PDF preview
×